Hansen, A. R., Ala‐Leppilampi, K., McKillop, C., Siu, L. L., Bedard, P. L., Abdul Razak, A. R., Spreafico, A., Sridhar, S. S., Leighl, N., Butler, M. O., Hogg, D., Sacher, A., Oza, A. M., Al‐Agha, R., Maurice, C., Chan, C. T., Shapera, S., Feld, J. J., Nisenbaum, R., Webster, K., Cella, D., & Parsons, J. (2020). development of the Functional Assessment of Cancer Therapy–Immune Checkpoint Modulator (FACT‐ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs. Cancer, 126(7), 1550–1558. http://access.bl.uk/ark:/81055/vdc_100102673613.0x00005a